AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 70 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.08 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $587,000 | +16.9% | 35,141 | +0.9% | 0.00% | 0.0% |
| Q1 2020 | $502,000 | -68.2% | 34,837 | -26.1% | 0.00% | -50.0% |
| Q4 2019 | $1,579,000 | +192.4% | 47,165 | +83.0% | 0.00% | +100.0% |
| Q3 2019 | $540,000 | +1284.6% | 25,777 | +1693.8% | 0.00% | – |
| Q2 2018 | $39,000 | -13.3% | 1,437 | +1.1% | 0.00% | – |
| Q1 2018 | $45,000 | -19.6% | 1,422 | -4.7% | 0.00% | – |
| Q4 2017 | $56,000 | +69.7% | 1,492 | +11.3% | 0.00% | – |
| Q3 2017 | $33,000 | +26.9% | 1,340 | +5.8% | 0.00% | – |
| Q2 2017 | $26,000 | -7.1% | 1,267 | -1.6% | 0.00% | – |
| Q1 2017 | $28,000 | +7.7% | 1,288 | -0.2% | 0.00% | – |
| Q4 2016 | $26,000 | +52.9% | 1,290 | +13.1% | 0.00% | – |
| Q3 2016 | $17,000 | +21.4% | 1,141 | -9.1% | 0.00% | – |
| Q2 2016 | $14,000 | -33.3% | 1,255 | -17.9% | 0.00% | – |
| Q1 2016 | $21,000 | – | 1,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 414,500 | $14,280,000 | 13.67% |
| Burrage Capital Management LLC | 332,546 | $11,456,000 | 9.04% |
| Penn Mutual Asset Management, LLC | 158,783 | $5,470,000 | 7.72% |
| First Trust Capital Management L.P. | 525,598 | $18,107,000 | 4.87% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 653,711 | $22,520,000 | 4.08% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,075,100 | $71,488,000 | 3.76% |
| S. MUOIO & CO. LLC | 90,000 | $3,101,000 | 3.52% |
| EQUITEC PROPRIETARY MARKETS, LLC | 124,700 | $4,296,000 | 3.27% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 501,719 | $17,284,000 | 3.11% |
| WATER ISLAND CAPITAL LLC | 1,062,245 | $36,594,000 | 3.11% |